Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

循环肿瘤细胞（CTCs）从肿瘤脱落进入血液，是癌症转移的关键环节，其存在与患者预后不良、复发及耐药相关。CTCs 分为单细胞 CTCs（scCTCs）和多细胞聚集体 cCTCs。cCTCs 虽数量稀少，却具有比 scCTCs 高 23 - 50 倍的转移潜能，在多种癌症患者血液中的存在与不良预后相关 。然而，由于其罕见性、短寿命和易在剪切力下解聚的特性，cCTCs 的分离极具挑战。

编辑丨王多鱼排版丨水成文抗 PD-1 联合仑伐替尼（lenvatinib，一种多靶点受体酪氨酸激酶抑制剂）治疗在多种肿瘤中均显示出临床疗效，但潜在的免疫学机制尚不清楚。2025 年 1 月 30 ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the ...

近年来，液体活检（liquid biopsies）作为一种侵入性较小的诊断方法，已经成为癌症研究的重要焦点。通过微创液体活检分析循环肿瘤DNA（circulating tumor DNA, ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

Researchers propose a novel system that uses standing surface acoustic waves to separate circulating tumor cells from red blood cells with unprecedented precision and efficiency. The platform ...